Clinical Actionability of Measurable Residual Disease (MRD) Assessment in the Management of Patients With Hematologic Malignancies: A Case-Based Monograph CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY Wolf, J., Fonseca, R., Muffly, L. 2020; 18 (3)

View details for Web of Science ID 000619716900001